CreatorsPublishersAdvertisers
View more in
Medical & Biotech

FDA Places Hold on BioMarin’s PKU Gene Therapy

Phramalive.com
 2021-09-07

Cover picture for the articleA string of gene therapy clinical trials have been paused due to safety concerns. The most recent is BioMarin Pharmaceutical, which announced that the U.S. Food and Drug Administration (FDA) had placed a clinical hold on its BMN 307 Phearless Phase I/II study. The trial investigates BMN 307, an AAV5-phenylalanine hydroxylase...

www.pharmalive.com

Comments / 0

Comments / 0